Cargando…

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors

BACKGROUND: Findings from previous studies regarding the association between the CYP17 genotype and breast cancer are inconsistent. We investigated the role of the MspAI genetic polymorphism in the 5' region of CYP17 on risk of breast cancer and as a modifier of reproductive risk factors. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ambrosone, Christine B, Moysich, Kirsten B, Furberg, Helena, Freudenheim, Jo L, Bowman, Elise D, Ahmed, Sabrina, Graham, Saxon, Vena, John E, Shields, Peter G
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154148/ https://www.ncbi.nlm.nih.gov/pubmed/12631398

Ejemplares similares

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study
por: Chang, Jiun-Horng, et al.
Publicado: (2005)

A polymorphism in the CYP17 gene is associated with male breast cancer
por: Young, I E, et al.
Publicado: (1999)

Alcohol’s Effects on Breast Cancer in Women
por: Freudenheim, Jo L.
Publicado: (2020)

Trends in Cruciferous Vegetable Consumption and Associations with Breast Cancer Risk: A Case-Control Study
por: Lin, Tengda, et al.
Publicado: (2017)

Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk
por: Rizzolo, Piera, et al.
Publicado: (2019)

No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.
por: Dunning, A. M., et al.
Publicado: (1998)

No Association of the 5′Promoter Region Polymorphism of CYP17 with Breast Cancer Risk in Japan
por: Hamajima, Nobuyuki, et al.
Publicado: (2000)

CYP17 promoter polymorphism and breast cancer risk in males and females in relation to BRCA2 status
por: Gudmundsdottir, K, et al.
Publicado: (2003)

CYP17 and breast cancer: no overall effect, but what about interactions?
por: Little, Julian, et al.
Publicado: (2005)

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study
por: Einarsdóttir, Kristjana, et al.
Publicado: (2005)

Assessing spatio-temporal variability of risk surfaces using residential history data in a case control study of breast cancer
por: Han, Daikwon, et al.
Publicado: (2005)

Association between CYP17 T-34C rs743572 and breast cancer risk
por: Sun, Jing, et al.
Publicado: (2017)

CYP17 MspA1 Gene Polymorphism and Breast Cancer Patients According to Age of Onset in Cancer Institute of Iran
por: EBRAHIMI, Elmira, et al.
Publicado: (2017)

Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk
por: Ricks-Santi, Luisel J, et al.
Publicado: (2011)

Genome-wide methylation patterns provide insight into differences in breast tumor biology between American women of African and European ancestry
por: Ambrosone, Christine B., et al.
Publicado: (2013)

The promise and limitations of genome-wide association studies to elucidate the causes of breast cancer
por: Ambrosone, Christine B
Publicado: (2007)

Landscape of genome-wide age-related DNA methylation in breast tissue
por: Song, Min-Ae, et al.
Publicado: (2017)

A polymorphic tetranucleotide repeat in the CYP19 gene and male breast cancer
por: Young, I E, et al.
Publicado: (2000)

Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: a family-based genetic association study
por: Ahsan, Habibul, et al.
Publicado: (2005)

CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case–control study
por: Yang, Pengtao, et al.
Publicado: (2018)

Social Trauma as Related to Cancer of the Breast
por: Snell, Laura, et al.
Publicado: (1971)

Genetic variants of CYP19 (aromatase) and breast cancer risk
por: Nedelcheva Kristensen, V, et al.
Publicado: (2000)

CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients
por: Jernström, H, et al.
Publicado: (2009)

CYP17, GSTP1, PON1 and GLO1 gene polymorphisms as risk factors for breast cancer: an Italian case-control study
por: Antognelli, Cinzia, et al.
Publicado: (2009)

Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors
por: Kwan, Marilyn L, et al.
Publicado: (2009)

Association of CYP19 polymorphisms with breast cancer risk: A case-control study
por: Surekha, Damineni, et al.
Publicado: (2014)

Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population
por: AL-Eitan, Laith N., et al.
Publicado: (2019)

CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case–control study
por: Verla-Tebit, Emaculate, et al.
Publicado: (2005)

CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset
por: Damkier, Per, et al.
Publicado: (2017)

CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer
por: Aiyappa‐Maudsley, Radhika, et al.
Publicado: (2022)

Association between manganese superoxide dismutase promoter gene polymorphism and breast cancer survival
por: Martin, Robert CG, et al.
Publicado: (2006)

Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers: a case-control study
por: Tang, Li, et al.
Publicado: (2010)

Effects of CYP2D6 and CYP3A5 polymorphisms on tamoxifen and its metabolites in Thai breast cancer patients
por: Charoenchokthavee, Wanaporn, et al.
Publicado: (2017)

Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis
por: Artigalás, Osvaldo, et al.
Publicado: (2015)

Discovery and replication of microRNAs for breast cancer risk using genome-wide profiling
por: Taslim, Cenny, et al.
Publicado: (2016)

Analysis of the rs10046 Polymorphism of Aromatase (CYP19) in Premenopausal Onset of Human Breast Cancer
por: Zins, Karin, et al.
Publicado: (2014)

IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines
por: Zhu, XingWu, et al.
Publicado: (2008)

Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer
por: Colomer, R, et al.
Publicado: (2005)

The associations of genetic polymorphisms in CYP1A2 and CYP3A4 with clinical outcomes of breast cancer patients in northern China
por: Bai, Xianan, et al.
Publicado: (2017)

Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0dtr2kieo4kuisbh0uoblt5iue